Cancer - Mel Greaves

Cancer

The Evolutionary Legacy

(Autor)

Buch | Softcover
288 Seiten
2001
Oxford University Press (Verlag)
978-0-19-262834-3 (ISBN)
107,20 inkl. MwSt
In this fascinating and highly readable new book, Mel Greaves shows how the origins of cancer are inextricably linked with our evolutionary heritage, and considers the implications of this theory for future research and treatment.
In this lucid and entertaining book, Mel Greaves argues that evolutionary biology offers a new perspective that can help us unravel the riddle of cancer. Why, for example, have women always had such a raw deal in the cancer stakes? And why are some cancers, such as prostate cancer, increasing in incidence?

Greaves argues that Darwinian selection millions of years ago has endowed our genes and cells with inherently cancerous credentials, and this is exacerbated by our rapid social evolution and exotic behavioural traits that outpace genetic adaptation. The book is full of novel insights, the latest scientific discoveries, and wonderful historical anecdotes. It provides a unique portrait of cancer, past, present, and future.

Mel Greaves is Director of the Leukemia Research Fund Center at the Institute of Cancer Research, in London. The winner of several awards for cancer research, he lives in London.

Preface ; PART I: CANCER - ANCIENT LEGACIES AND MODERN MYTHS ; 1. Perplexed? You should be ; 2. The King of Naples and other silent witnesses ; 3. Questions and answers ; PART II: EVOLVING CANCER ; 4. Clones, clones, clones ; 5. The way we are: risk and restraints ; 6. How cancer cells play the winning game ; 7. Green-eyed mutations? ; 8. Blind chance - and ultimate extinction? ; PART III: PARADOXES OF PROGRESS: INDECENT EXPOSURES ; 9. Is cancer an evolutionary inevitability? ; 10. And then you set fire to it? ; 11. Women's troubles ; 12. Men's troubles ; 13. Cancer a deux ; 14. Other ways of getting bugged ; 15. Travelling light ; 16. Dying for a living ; 17. Collateral damage ; 18. Finale: compounding risk with bad luck ; PART IV: FINESSING THE CLONE ; 19. Treatment: the blind marksman ; 20. Epilogue: cancer in the 21st century ; Index

Erscheint lt. Verlag 1.11.2001
Zusatzinfo 20 line, 20 halftone, 2 colour plates
Verlagsort Oxford
Sprache englisch
Maße 156 x 234 mm
Gewicht 451 g
Themenwelt Sachbuch/Ratgeber Gesundheit / Leben / Psychologie
Sachbuch/Ratgeber Natur / Technik
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Naturwissenschaften Biologie Evolution
ISBN-10 0-19-262834-8 / 0192628348
ISBN-13 978-0-19-262834-3 / 9780192628343
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99